The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $629,535 in first-year total cost, median $314,768.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]2
Most frequent institutions
- TULANE UNIVERSITY OF LOUISIANA2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Neutrophil-driven mucosal dysfunction in SIV/malaria co-infection1R21OD031435-01 | MANUZAK, JENNIFER | TULANE UNIVERSITY OF LOUISIANA, LA | $340,000 | HIVD |
| 2021 | Mechanisms and Therapeutic Targeting of CD4 Down regulation in African Green Monkeys1R21OD031229-01 | MUDD, JOSEPH CHRISTOPHER | TULANE UNIVERSITY OF LOUISIANA, LA | $289,535 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.